Hunan Zhaotai Yongren Medical

Hunan Zhaotai Yongren Medical is a Chinese biotechnology firm focused on the research and development of innovative cell-based immunotherapies. The company operates as a core component of the Hunan Zhaotai Medical Group, specializing in chimeric antigen receptor T-cell (CAR-T) therapies for various cancers. Their research portfolio addresses significant unmet needs in both liquid and solid tumors, with a particular emphasis on B-cell malignancies and liver cancer. By integrating advanced genetic engineering with clinical application, the company aims to provide high-efficacy treatments for patients globally. Zhaotai Yongren maintains state-of-the-art manufacturing facilities to support its clinical trial pipeline and future commercialization efforts.